MYH9 Genetic Variants Associated With Glomerular Disease: What Is the Role for Genetic Testing?
- 31 July 2010
- journal article
- Published by Elsevier BV in Seminars in Nephrology
- Vol. 30 (4), 409-417
- https://doi.org/10.1016/j.semnephrol.2010.06.007
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Association of Trypanolytic ApoL1 Variants with Kidney Disease in African AmericansScience, 2010
- Glomerular pathology in autosomal dominant MYH9 spectrum disorders: what are the clues telling us about disease mechanism?Kidney International, 2010
- Genetics of Focal Segmental Glomerulosclerosis and Human Immunodeficiency Virus–Associated Collapsing Glomerulopathy: The Role of MYH9 Genetic VariationSeminars in Nephrology, 2010
- Dense mapping of MYH9 localizes the strongest kidney disease associations to the region of introns 13 to 15Human Molecular Genetics, 2010
- Actin, a Central Player in Cell Shape and MovementScience, 2009
- Non-muscle myosin II takes centre stage in cell adhesion and migrationNature Reviews Molecular Cell Biology, 2009
- Non-muscle myosin heavy chain 9 gene MYH9 associations in African Americans with clinically diagnosed type 2 diabetes mellitus-associated ESRDNephrology Dialysis Transplantation, 2009
- Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African AmericansKidney International, 2009
- MYH9 is associated with nondiabetic end-stage renal disease in African AmericansNature Genetics, 2008
- MYH9 is a major-effect risk gene for focal segmental glomerulosclerosisNature Genetics, 2008